Histoplasma capsulatum prosthetic valve endocarditis treated with oral isavuconazole

Area of Science:

• Mycology
• Infectious Diseases
• Cardiology

Background:

• Histoplasma capsulatum is a common cause of fungal infections in the US, particularly severe in immunocompromised individuals.
• Histoplasmosis endocarditis is an uncommon manifestation of H. capsulatum infection, with limited treatment guidelines.
• Fungal endocarditis poses significant risks, especially in patients with prosthetic valves.

Observation:

• A rare case of Histoplasma endocarditis involving an artificial aortic valve was observed.
• The patient presented with complications necessitating surgical intervention and antifungal treatment.
• Isavuconazole was chosen due to potential tolerability issues with conventional antifungal agents.

Findings:

• Successful treatment was achieved through a combination of aortic valve replacement and isavuconazole therapy.
• This case highlights the successful use of isavuconazole in managing prosthetic valve histoplasmosis endocarditis.
• Surgical intervention combined with targeted antifungal therapy proved effective.

Implications:

• This case expands the understanding of Histoplasma endocarditis management, particularly in prosthetic valve settings.
• Isavuconazole represents a viable therapeutic option for histoplasmosis endocarditis, offering an alternative to traditional antifungals.
• Further research into optimal antifungal strategies for rare fungal endocarditis cases is warranted.